BDX - Becton, Dickinson and Company
| Previous Close | 232.16 |
| Open | 230.26 |
| Bid | 209.30 x 800 |
| Ask | 0.00 x 1200 |
| Day's Range | 227.06 - 231.63 |
| 52 Week Range | 191.53 - 248.39 |
| Volume | 1,039,815 |
| Avg. Volume | 1,158,009 |
| Market Cap | 61.748B |
| Beta | 1.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.42 |
| Earnings Date | Aug 1, 2018 - Aug 6, 2018 |
| Forward Dividend & Yield | 3.00 (1.29%) |
| Ex-Dividend Date | 2018-06-07 |
| 1y Target Est | 252.65 |
- Zacks•4 days ago
Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health
Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health
- Simply Wall St.•5 days ago
Is Becton Dickinson and Company’s (NYSE:BDX) Balance Sheet Strong Enough To Weather A Storm?
Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Becton Dickinson and Company (NYSE:BDX) a safer option. Risk-averse investors who are attracted to diversifiedRead More...
- Zacks•8 days ago
Top Research Reports for Disney, Caterpillar & MetLife
Top Research Reports for Disney, Caterpillar & MetLife
- GlobeNewswire•8 days ago
Report: Exploring Fundamental Drivers Behind Matthews International, Raytheon, JetBlue Airways, Repligen, Becton, Dickinson, and Macy's — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, June 11, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Matthews ...
Markit•11 days agoSee what the IHS Markit Score report has to say about Becton Dickinson and Co.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Zacks•13 days ago
Becton, Dickinson Ties Up With Helmer Scientific to Boost MMS
Becton, Dickinson (BDX) aims to boost its MMS segment through the promotion of its Pyxis ES refrigerator.
- ACCESSWIRE•14 days ago
Akers Biosciences and Three Additional Stocks Under Scanner in the Medical Supplies Space
LONDON, UK / ACCESSWIRE / June 5, 2018 / If you want a free Stock Review on AKER sign up now at www.wallstequities.com/registration. This Tuesday, WallStEquities.com has initiated reports coverage on the following Medical Instruments & Supplies equities: Akers Biosciences Inc. (NASDAQ: AKER), Antares Pharma Inc. (NASDAQ: ATRS), Baxter International Inc. (NYSE: BAX), and Becton, Dickinson and Co. (NYSE: BDX).
- ACCESSWIRE•14 days ago
Free Research Report as Becton, Dickinson and Co.'s Revenues Surged 42.2%; Adjusted Earnings Soared 15.2%
LONDON, UK / ACCESSWIRE / June 5, 2018 / If you want access to our free earnings report on Becton, Dickinson and Co. (NYSE: BDX) ("BD"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BDX. The Company reported its financial results on May 03, 2018, for the second quarter of the fiscal year 2018 (Q2 FY18). The global medical technology Company surpassed market estimates for revenues and earnings for Q2 FY18.
- PR Newswire•14 days ago
/C O R R E C T I O N -- BD (Becton, Dickinson and Company)/
In the news release, BD to Present at Investor Healthcare Conferences, issued June 1, 2018 by BD (Becton, Dickinson and Company) over PR Newswire, we are advised by the company that the Goldman Sachs 38th ...
- Investopedia•15 days ago
9 Stocks Poised for Healthy Long-Term Gains
Stock investors looking for long-term growth plays in the health care space may seek guidance from Fidelity Fund manager Eddie Yoon, who oversees more than $35 billion in assets and leads the firm's health sector with a team of 12 investment professionals.
- PR Newswire•15 days ago
BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution
BD Pyxis™ ES Refrigerator Expands Enterprise-wide Medication Management Solutions from BD to Improve Refrigerated Medication Management and Security First Demonstration Unveiled During 2018 American Society ...
- Zacks•15 days ago
Why Is Becton, Dickinson (BDX) Down 2.4% Since its Last Earnings Report?
Becton, Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire•18 days ago
BD to Present at Investor Healthcare Conferences
FRANKLIN LAKES, N.J. , June 1, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming ...
- Barrons.com•18 days ago
[$$] In Health Care, Fidelity Targets Secular Growth
Eddie Yoon spent his college years studying premed and playing golf at Brown University. Joining the firm as an analyst in 2006, he rose quickly, becoming portfolio manager of Fidelity Select Medical Technology and Devices Portfolio (FSMEX) in 2007 and Fidelity Select Health Care Portfolio (FSPHX) in 2008.
- PR Newswire•18 days ago
BD Names John DeFord Chief Technology Officer
FRANKLIN LAKES, N.J., June 1, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today appointed John A. DeFord as executive vice president and chief technology officer. DeFord, 56, will report to Tom Polen, president of BD, and will be responsible for leading all research and development (R&D) activities for the company, including developing the current and future product portfolio. Since the completion of the C. R. Bard, Inc. transaction, DeFord has served as senior vice president of R&D for the Interventional Segment at BD.
Markit•20 days agoSee what the IHS Markit Score report has to say about Becton Dickinson and Co.
Becton Dickinson and Co NYSE:BDX
- TheStreet.com•21 days ago
Medical Device Stocks Could Be Gearing Up to Be Market Leaders
Medical devices is another industry that Jim Cramer believes will hold up better in this current environment of volatile energy prices and interest rates. Let's take a look at five companies in this space, Baxter International Inc. The chart and indicators of Baxter International show underlying strength and could outperform the averages in the days and weeks ahead.
- Simply Wall St.•29 days ago
What Is Becton Dickinson and Company’s (NYSE:BDX) Share Price Doing?
Today we’re going to take a look at the well-established Becton Dickinson and Company (NYSE:BDX). The company’s stock received a lot of attention from a substantial price movement on theRead More...
- Simply Wall St.•last month
What does Budimex SA’s (WSE:BDX) Balance Sheet Tell Us About Its Future?
While small-cap stocks, such as Budimex SA (WSE:BDX) with its market cap of ZŁ4.67B, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...
- Reuters•last month
U.S. investigates bloodstream infections for link to heparin syringes
SHANGHAI/CHICAGO, May 11 (Reuters) - Health agencies are investigating an outbreak of bloodstream infections in children from four U.S. states that may be linked to heparin and saline syringes made by Becton Dickinson and Co, the agencies told Reuters. The U.S. Centers for Disease Control and Prevention has confirmed 14 cases of bloodstream infections in children caused by the same strain of the Serratia marcescens bacterium, the agency's lead investigator on the outbreak said in a telephone interview.
Markit•last monthSee what the IHS Markit Score report has to say about Becton Dickinson and Co.
Becton Dickinson and Co NYSE:BDX
- ACCESSWIRE•last month
Free Post Earnings Research Report: Illumina’s Quarterly Revenue Surged 31%; Adjusted EPS Soared 127%
LONDON, UK / ACCESSWIRE / May 08, 2018 / If you want access to our free earnings report on Illumina, Inc. (NASDAQ: ILMN), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ILMN. Illumina reported its first quarter fiscal 2018 operating and financial results on April 24, 2018. The genetic testing tools Company outperformed top- and bottom-line expectations.
- Motley Fool•last month
Becton, Dickinson Starts the Bard Integration Off on a Solid Note
The medical supply company looks for margin expansion in the coming quarters.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of BDX earnings conference call or presentation 3-May-18 12:00pm GMT
Q2 2018 Becton Dickinson and Co Earnings Call
- Market Realist•2 months ago
Becton Dickinson Reports 2Q18 Earnings Results
Today, Becton, Dickinson and Company (BDX), or BD, released its 1Q18 earnings results for the quarter that ended on March 31. The company reported strong sales and earnings results, surpassing Wall Street estimates. Also, BD raised its fiscal 2018 outlook during its 2Q18 earnings release.
